These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3731033)

  • 1. Simultaneous in vitro drug sensitivity testing on tumors from different sites in the same patient.
    Von Hoff DD; Clark GM; Forseth BJ; Cowan JD
    Cancer; 1986 Sep; 58(5):1007-13. PubMed ID: 3731033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heterogeneity in drug sensitivity of human tumors in the human tumor colony-forming assay].
    Tanigawa N; Mizuno Y; Honda K; Hashimura T; Satomura K; Hikasa Y
    Nihon Geka Gakkai Zasshi; 1983 Sep; 84(9):800-803. PubMed ID: 6676649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in growth pattern and drug sensitivity of primary tumor and metastases in the human tumor colony-forming assay.
    Schlag P; Schreml W
    Cancer Res; 1982 Oct; 42(10):4086-9. PubMed ID: 7105006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of human metastatic clones by in vitro chemosensitivity testing. Implications for the clinical application of the clonogenic assay.
    Bertelsen CA; Korn EI; Morton DL; Kern DH
    Arch Surg; 1983 Dec; 118(12):1406-9. PubMed ID: 6651518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of in vitro chemosensitivity assays: human tumor clonogenic and scintillation assay].
    Tanigawa N; Morimoto H; Akita T; Inoue H; Tanaka T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1176-84. PubMed ID: 3729439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of drug sensitivity among tumor cells within a tumor, between primary tumor and metastases, and between different metastases in the human tumor colony-forming assay.
    Tanigawa N; Mizuno Y; Hashimura T; Honda K; Satomura K; Hikasa Y; Niwa O; Sugahara T; Yoshida O; Kern DH
    Cancer Res; 1984 Jun; 44(6):2309-12. PubMed ID: 6202397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning of pediatric malignancies for drug sensitivity testing in the human tumor cloning assay.
    Morris GL; Zeltzer PM; Schneider SL; Von Hoff DD
    Am J Pediatr Hematol Oncol; 1986; 8(1):52-7. PubMed ID: 3013039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiences with the human tumor colony-forming assay in gynecologic malignancies.
    Umbach GE; Poethen J; von Matthiessen H; Bender HG; Koldovsky U
    J Cancer Res Clin Oncol; 1985; 110(3):234-7. PubMed ID: 4077921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UICC Study Group on chemosensitivity testing of human tumors. Problems--applications--future prospects.
    Pihl A
    Int J Cancer; 1986 Jan; 37(1):1-5. PubMed ID: 3941017
    [No Abstract]   [Full Text] [Related]  

  • 10. The human tumor cloning assay in cancer drug development. A review.
    Agre P; Williams TE
    Invest New Drugs; 1983; 1(1):33-45. PubMed ID: 6381376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug sensitivity testing of gynecologic tumors using Volm's test and stem cell assay].
    Eidtmann H; Jonat W; Maass H
    Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):477-81. PubMed ID: 4029587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug sensitivity testing of carcinoma of the gallbladder and biliary tree in a human tumor cloning assay.
    Harris GJ; Von Hoff DD
    Cancer Drug Deliv; 1986; 3(3):197-204. PubMed ID: 3779604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity and variability of test results as limiting factors for predictive assays.
    Schlag P; Flentje D
    Recent Results Cancer Res; 1984; 94():191-6. PubMed ID: 6494579
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of the tumor colony assay in therapy planning in malignant ovarian tumors].
    Schieder K; Kölbl H; Bieglmayer C
    Geburtshilfe Frauenheilkd; 1987 Jan; 47(1):41-4. PubMed ID: 3569826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sensitivity testing of anticancer drugs using the human tumor clonogenic assay].
    Hiraki S; Ohnoshi T; Kishimoto N; Mori K; Nishii K; Yonei T; Yamashita H; Kimura I
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1208-13. PubMed ID: 3729443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
    Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a human tumor colony-forming assay to new drug screening.
    Shoemaker RH; Wolpert-DeFilippes MK; Kern DH; Lieber MM; Makuch RW; Melnick NR; Miller WT; Salmon SE; Simon RM; Venditti JM
    Cancer Res; 1985 May; 45(5):2145-53. PubMed ID: 3986767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of nude mouse xenografts as preclinical drug screens. Further studies on in vitro growth of xenograft tumor colony-forming cells.
    Taetle R; Honeysett JM; Rosen F; Shoemaker R
    Cancer; 1986 Nov; 58(9):1969-78. PubMed ID: 3756816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician.
    Von Hoff DD; Sandbach JF; Clark GM; Turner JN; Forseth BF; Piccart MJ; Colombo N; Muggia FM
    J Natl Cancer Inst; 1990 Jan; 82(2):110-6. PubMed ID: 2403593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro chemosensitivity of lung cancer and other chest tumors evaluated by human tumor colony assay].
    Lee K; Kuze F; Hashimura T; Tanigawa N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2537-43. PubMed ID: 6095761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.